Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches

Table 3

Laboratory assays in the study group, depending on the type of disease-modifying therapy without the assessment of healthy controls.

Parameters	IFN-β	IFN-β1b
	22	17	5	7	12
[µM]						0.018
IL-1β/IL- [pg/mL]						0.78
[mg/L]						0.79

A: nitric oxide (nitrite and nitrate); b: interleukin; c: C-reactive protein; d: interferon beta; e: glatiramer acetate; f: natalizumab; g: fingolimod.